Genomics, type 2 diabetes, and obesity.
By Mark I. McCarthy. New England Journal of Medicine, 2010
981 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/bac5dadbc1c29ba537032d5d358816dbec7dce5a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
- Joshua Charles Denny
- Wei-Qi Wei
- Terrie E. Moffitt
- Avshalom Caspi
- M. Cerf
- Leif Groop
- C. Ling
- Christopher G. Chute
In Surgery
Citations in the corpus
- A Six Months Exercise Intervention Influences the Genome-wide DNA Methylation Pattern in Human Adipose Tissue (2013, positive): “Importantly, although each variant only contributes with a small risk, these findings have led to improved understanding of the biological basis of disease [3].”
- Pathophysiology of Type 2 Diabetes Mellitus (2020, background): “Over the past decade, several T2DM genome-wide association studies have shown the complex polygenic nature of T2DM in which most of these loci increase T2DM risk through primary effects on insulin secretion, and a minority act through reducing insulin action [21,22].”
- Development and Evaluation of a Genetic Risk Score for Obesity (2013, background): “A key challenge in this effort is that obesity’s genetic roots are diffuse, multifactorial, and nondeterministic; many variants scattered across the genome each contribute small risks for obesity (McCarthy 2010).”
- Beta Cell Dysfunction and Insulin Resistance (2013, background): “…in beta cell dysfunction) rather than insulin action (resulting in insulin resistance) which establishes that inherited abnormalities of beta cell function or mass (or both) are critical precursors in type 2 diabetes (Florez, 2008; McCarthy, 2010; Voight et al., 2010; Petrie et al., 2011).”
- Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments (2023, background): “Frontiers in Endocrinology 04 development and function (18, 21) (Figure 1).”
- Globalization of Diabetes (2011, background): “GENETIC SUSCEPTIBILITY AND GENE-ENVIRONMENT INTERACTIONS—The recent advent of genome-wide association studies (GWAS) has led to major advances in the identification of common genetic variants contributing to diabetes susceptibility (40).”
- Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study (2012, background): “However, the genetic underpinnings of T1D and T2D differ.(18) 19 Second, although T2D is increasingly common in youth and young adults, onset is typically later in life, complicating the identification of a control group at low risk of T2D.”